General Information of the Cell Line
Cell Line ID
CL000108
Cell Line Name
CCRF-CEM
Synonyms
CCRF/CEM
CCRFCEM
CCRF.CEM
CCRF CEM
CCRF
CEM
CEM-CCRF
CEM-CCRF (CAMR)
CCRF/CEM/0
CEM/0
CEM-0
CCRF-CEM/S
GM03671
GM03671C
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0207
Tissue Information
Peripheral blood
Disease
Childhood T acute lymphoblastic leukemia (NCIt: C7953)
Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01546, ATP-dependent translocase ABCB1
 Protein Info 
Compound ID Compound Name Compound Formula
CP0458716
 Compound Info 
(3S,6S,9S,12R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-15-propan-2-ylidene-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H90N8O10
  1
1
IC50 = 180 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0535520
 Compound Info 
(3S,6S,9S,12R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 360 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0408797
 Compound Info 
(3S,6S,9S,12R,15R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 390 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0501194
 Compound Info 
(3S,6S,9S,12R,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C57H86N8O10
  1
1
IC50 = 890 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0930903
 Compound Info 
5,8-Dibenzyl-14,26-di-sec-butyl-17-(2-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 1090 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0374235
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,27S)-3,6-dibenzyl-24-[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,12,21-tri(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C59H90N8O11
  1
1
IC50 = 1100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0883089
 Compound Info 
5,8-Dibenzyl-14-sec-butyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23,26-triisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H90N8O11
  1
1
IC50 = 1290 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0397500
 Compound Info 
(3S,6S,9S,12R,18R,21S,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3-propan-2-yl-21,30-dipropyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O12
  1
1
IC50 = 1300 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0860303
 Compound Info 
8-Benzyl-14,26-di-sec-butyl-5-(hydroxy-phenyl-methyl)-20-isobutyl-11,17,23-triisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 1360 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436734
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-3-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-21-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O12
  1
1
IC50 = 1500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0847531
 Compound Info 
27-Benzyl-30-ethyl-33-(1-hydroxy-2-methyl-hept-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C70H119N11O12
  1
1
IC50 = 1500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0880818
 Compound Info 
21',24'-dibenzyl-3',15'-di(sec-butyl)-9'-isobutyl-6',18'-diisopropyl-3,3,5',11',17',23'-hexamethylspiro[dihydrooxirane-2,12'-perhydropyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine]-1',4',7',10',13',16',19',22',25'-nonaone
   Show/Hide
C60H90N8O11
  1
1
IC50 = 1550 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0377806
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,19,25,28-heptamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O14
  1
1
IC50 = 1600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430233
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-12-[(2S)-butan-2-yl]-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,19,25,28-heptamethyl-9,15,30,33-tetrakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O14
  1
1
IC50 = 1600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0403760
 Compound Info 
(3S,6S,9S,12R,15S,18S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16-trimethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13,22-dioxa-1,4,7,10,16,19,25-heptazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C59H89N7O12
  1
1
IC50 = 1660 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383533
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 1900 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436807
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,21,24-pentakis(2-methylpropyl)-3-propan-2-yl-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 2000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0466933
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 2000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383528
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,19,25,28-heptamethyl-9,15,30,33-tetrakis(2-methylpropyl)-3,12,27-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O14
  1
1
IC50 = 2100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0454670
 Compound Info 
(3S,6S,9R,12S,15R,18R,21R,27S,33S)-30-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,9,12,16,22,25-octamethyl-3,6,15,21-tetrakis(2-methylpropyl)-18,27,33-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 2100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0397299
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-12,24-bis[(2S)-butan-2-yl]-6-[[4-(cyclohexylmethoxy)phenyl]methyl]-15-(2-hydroxypropan-2-yl)-3,4,10,16,22-pentamethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C61H100N8O12
  1
1
IC50 = 2110 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0880790
 Compound Info 
8-Benzyl-14,26-di-sec-butyl-17-(1-hydroxy-1-methyl-ethyl)-5-(hydroxy-phenyl-methyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C60H92N8O12
  1
1
IC50 = 2150 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0409417
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O11
  1
1
IC50 = 2200 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0465372
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 2270 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0375423
 Compound Info 
(3S,6S,9R,12S,15R,18R,21R,27S,33S)-27-ethyl-30-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,9,12,16,22,25-octamethyl-3,6,15,21-tetrakis(2-methylpropyl)-18,33-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 2300 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0395441
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-24-benzyl-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C66H111N11O12
  1
1
IC50 = 2400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0845643
 Compound Info 
5,8-Dibenzyl-14,26-di-sec-butyl-20-isobutyl-11,17,23-triisopropyl-6,12,18-trimethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H90N8O10
  1
1
IC50 = 2680 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0874522
 Compound Info 
6,9,18,24-Tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-(2-methyl-hept-4-enyl)-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C64H115N11O11
  1
1
IC50 = 2700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0458656
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 = 2730 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0404597
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28,30-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H107N11O12
  1
1
IC50 = 3000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0036222
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 3400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0405766
 Compound Info 
(3S,6R,9S,12R,15R,18R,24S,27S,30S,33S)-24-ethyl-27-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,6,9,13,19,22,28-octamethyl-3,12,18,33-tetrakis(2-methylpropyl)-15,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 3400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0948457
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-21-isopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-3-(1-methyl-allyl)-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C63H111N11O12
  1
1
IC50 = 3400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0897117
 Compound Info 
cyclo-[MeBmt-Abu-D-Pro-MeLeu-Val-MeLeu-Ala-D-Ala-MeLeu-MeLeu-MeVal]
   Show/Hide
C62H111N11O12
  1
1
IC50 = 3500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430546
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,16,25,28-hexamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O14
  1
1
IC50 = 4000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0487542
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-hexyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H111N11O11
  1
1
IC50 = 4000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430441
 Compound Info 
(3S,6S,9R,12S,15S,21S,24S,27S,30S,33S)-3-hydroxy-21-[(1R)-1-hydroxyethyl]-24-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,6,10,19,25,28-hexamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O14
  1
1
IC50 = 4300 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0932129
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hept-4-enyl)-6,9,24-triisobutyl-3,21-diisopropyl-1,4,7,10,12,15,18,19,25,28-decamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C60H107N11O12
  1
1
IC50 = 4600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0507105
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28,30-decamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 4700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0409931
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-6-benzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-3,4,10,16-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C53H86N8O11
  1
1
IC50 = 4790 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0463660
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 = 5100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0880813
 Compound Info 
14,26-Di-sec-butyl-8-cyclohexyl-5-hydroxymethyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C53H92N8O12
  1
1
IC50 = 5160 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0907022
 Compound Info 
cyclo-[MeBmt-Abu-L-Pro-MeLeu-Val-MeLeu-Ala-D-Ala-MeLeu-MeLeu-MeVal]
   Show/Hide
C62H111N11O12
  1
1
IC50 = 5200 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436760
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24,33-pentakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H109N11O11
  1
1
IC50 = 5600 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0463581
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 5700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0394178
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-12,24-bis[(2S)-butan-2-yl]-6-[(4-hydroxyphenyl)methyl]-15-(2-hydroxypropan-2-yl)-3,4,10,16,22-pentamethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C54H88N8O12
  1
1
IC50 = 5770 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0878679
 Compound Info 
5-Benzyl-14,26-di-sec-butyl-8-cyclohexyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18,24-tetramethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H96N8O11
  1
1
IC50 = 5880 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430513
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,21,24-pentakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O13
  1
1
IC50 = 6000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0448580
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-24-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O12
  1
1
IC50 = 6400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0466750
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24,33-pentakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H109N11O11
  1
1
IC50 = 7000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0453115
 Compound Info 
(3S,6S,9S,12S,24S,27R)-12,27-bis[(2S)-butan-2-yl]-3-(2-hydroxypropan-2-yl)-4,10,25-trimethyl-6-(2-methylpropyl)-9,24-di(propan-2-yl)-1-oxa-4,7,10,13,22,25-hexazacycloheptacosane-2,5,8,11,14,23,26-heptone
   Show/Hide
C44H80N6O9
  1
1
IC50 = 7420 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0912339
 Compound Info 
5,8-Dibenzyl-14,26-di-sec-butyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-6,12,18-trimethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C59H90N8O11
  1
1
IC50 = 7550 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0897852
 Compound Info 
30-Ethyl-6,9,18,24,33-pentaisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C59H107N11O11
  1
1
IC50 = 8000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0404315
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-(cyclohexylmethyl)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O11
  1
1
IC50 = 8100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0521923
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-21-[(2S)-butan-2-yl]-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 = 8400 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0373205
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 8800 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0392628
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 8800 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0374685
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21,24-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 = 11100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0908313
 Compound Info 
30-Ethyl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-(2-methyl-cyclohexyl)-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C62H111N11O11
  1
1
IC50 = 13100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0430232
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 = 14100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0506686
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-24-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,28-octamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 15000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0470388
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E)-3-methylhept-5-en-2-yl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O11
  1
1
IC50 = 15500 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0461449
 Compound Info 
(3S,6S,9R,12S,15R,21S,24S,27S,30S,33S)-24-[(E,1R,2R)-1,6-dihydroxy-2-methylhex-4-enyl]-3-hydroxy-21-[(1R)-1-hydroxyethyl]-1,6,10,16,19,25,28-heptamethyl-9,12,15,30,33-pentakis(2-methylpropyl)-3,27-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C64H115N11O15
  1
1
IC50 = 15800 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0453344
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,3,4,7,10,12,15,19,25,28-decamethyl-6,9,18,24-tetrakis(2-methylpropyl)-21-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H107N11O12
  1
1
IC50 = 16100 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383534
 Compound Info 
(3S,6S,9R,12S,15R,18R,21R,27S,33S)-27-[(1R)-1-hydroxyethyl]-30-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,9,12,16,22,25-octamethyl-3,6,15,21-tetrakis(2-methylpropyl)-18,33-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 = 17000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0429026
 Compound Info 
(3S,6R,9S,12R,15R,18R,24S,27S,30S,33S)-24-[(1R)-1-hydroxyethyl]-27-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,6,9,13,19,22,28-octamethyl-3,12,18,33-tetrakis(2-methylpropyl)-15,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 = 19000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0897053
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,25,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C61H109N11O12
  1
1
IC50 = 23000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0381082
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-24-(2-hydroxy-2-methylpropyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 > 30000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0454580
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-12-(hydroxymethyl)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,15,19,25-heptamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O13
  1
1
IC50 > 30000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0484579
 Compound Info 
(3R,6S,9S,12R,15S,18S,21S,24S,27S)-12,24-bis[(2S)-butan-2-yl]-6-(hydroxymethyl)-15-(2-hydroxypropan-2-yl)-3,4,10,16,22-pentamethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C48H84N8O12
  1
1
IC50 > 31000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0392627
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-12-(hydroxymethyl)-33-[(E,1R,2R)-1-hydroxy-2-methylhept-4-enyl]-1,4,7,10,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
  1
1
IC50 = 42000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0860289
 Compound Info 
15,30-Diethyl-33-(1-hydroxy-2-methyl-hept-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,19,25,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C64H115N11O12
  1
1
IC50 = 50000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0941694
 Compound Info 
33-(1,6-Dihydroxy-2-methyl-hex-4-enyl)-30-ethyl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C62H111N11O13
  1
1
IC50 = 50000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0845551
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C60H107N11O12
  1
1
IC50 > 54000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0392579
 Compound Info 
(3S,6S,9S,12R,15S,18R,21S,24R,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,6,10,12,15,19,25,28-nonamethyl-9,18,21,24-tetrakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C59H105N11O13
  1
1
IC50 = 56000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0383986
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C61H109N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0436735
 Compound Info 
(3S,6S,9S,12R,15S,18S,21R,24R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,10,12,15,25,28-heptamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C60H107N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0480618
 Compound Info 
(3S,6S,9S,12R,15S,18R,21R,24R,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C62H111N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0899557
 Compound Info 
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C61H109N11O12
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0916099
 Compound Info 
30-(1-Hydroxy-ethyl)-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C60H107N11O13
  1
1
IC50 > 100000 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0441218
 Compound Info 
(3S,6S,9S,12R,15S,18S,21S,24S,27R)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 > 2700 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0500984
 Compound Info 
(3S,6S,9S,12R,15S,18S,21R,24S,27S)-3,6-dibenzyl-12,24-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
   Show/Hide
C60H92N8O11
  1
1
IC50 > 2730 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0860194
 Compound Info 
14,26-Di-sec-butyl-8-cyclohexyl-17-(1-hydroxy-1-methyl-ethyl)-20-isobutyl-11,23-diisopropyl-5,6,12,18,24-pentamethyl-octadecahydro-15-oxa-3a,6,9,12,18,21,24,27-octaaza-cyclopentacycloheptacosene-4,7,10,13,16,19,22,25,28-nonaone
   Show/Hide
C53H92N8O11
  1
1
IC50 > 2910 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
CP0475613
 Compound Info 
3-[(3S,6S,9S,12R,15S,19R,23S,26S,29S)-3,6-dibenzyl-12,26-bis[(2S)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,24-tetramethyl-2,5,8,11,14,17,20,22,25,28-decaoxo-9,23-di(propan-2-yl)-13-oxa-1,4,7,10,16,18,21,24,27-nonazabicyclo[27.3.0]dotriacontan-19-yl]propanoic acid
   Show/Hide
C60H89N9O14
  1
1
IC50 > 8960 nM
 Bioactivity Info 
   TI
   LI
   LO
   TS
Protein ID: PT01508, C-C chemokine receptor type 4
 Protein Info 
Protein ID: PT02059, C-X-C chemokine receptor type 4
 Protein Info 
Protein ID: PT01831, Deoxycytidine kinase
 Protein Info 
Protein ID: PT01651, Dihydrofolate reductase
 Protein Info 
Protein ID: PT01873, Glycinamide ribonucleotide synthetase
 Protein Info 
Protein ID: PT01266, Muscarinic acetylcholine receptor M3
 Protein Info 
Protein ID: PT00004, Pol polyprotein
 Protein Info 
Protein ID: PT01171, Prostaglandin D2 receptor 2
 Protein Info 
Protein ID: PT00005, Reverse transcriptase/RNaseH
 Protein Info 
Protein ID: PT06950, Virion infectivity factor
 Protein Info 
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0002778
 Compound Info 
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
 C29H31N7O  2
1
IC50 = 36000 nM
   TI
   LI
   LO
   TS
2
IC50 = 45000 nM
   TI
   LI
   LO
   TS
CP0003198
 Compound Info 
N-(2,3-dihydroxypropyl)-4-[(1,3-dimethylpyrazolo[4,3-e][1,2,4]triazin-5-yl)amino]benzenesulfonamide
   Show/Hide
 C15H19N7O4S  1
1
IC50 = 57000 nM
   TI
   LI
   LO
   TS
CP0003433
 Compound Info 
(Arylindolyl)maleimide deriv. 27
   Show/Hide
 C21H16N4O2  1
1
GI50 = 2860 nM
   TI
   LI
   LO
   TS
CP0007711
 Compound Info 
(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-N'-propylprop-2-enehydrazide;2,2,2-trifluoroacetic acid
   Show/Hide
 C26H31F3N4O3  1
1
LC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0008814
 Compound Info 
4-[(1,3-dimethylpyrazolo[4,3-e][1,2,4]triazin-5-yl)amino]-N-(2-hydroxyethyl)benzenesulfonamide
   Show/Hide
 C14H17N7O3S  1
1
IC50 = 49000 nM
   TI
   LI
   LO
   TS
CP0014913
 Compound Info 
4-[(1,3-dimethylpyrazolo[4,3-e][1,2,4]triazin-5-yl)amino]-N-(1-hydroxy-3-methylbutan-2-yl)benzenesulfonamide
   Show/Hide
 C17H23N7O3S  1
1
IC50 = 54000 nM
   TI
   LI
   LO
   TS
CP0036197
 Compound Info 
2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
   Show/Hide
 C20H22N8O5  3
1
EC50 = 14 nM
   TI
   LI
   LO
   TS
2
EC50 = 18 nM
   TI
   LI
   LO
   TS
3
ED50 = 14.5 nM
   TI
   LI
   LO
   TS
CP0039390
 Compound Info 
(E)-4-(3-(hydroxyamino)-3-oxoprop-1-enyl)-N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)benzamide
   Show/Hide
 C25H21N5O3S  1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0040645
 Compound Info 
2-N-(2-aminophenyl)-5-N-[3-[(5-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]pyridine-2,5-dicarboxamide
   Show/Hide
 C27H21N7O2S  1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0041607
 Compound Info 
(AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
   Show/Hide
 C10H13N5O4  1
1
IC50 = 500000 nM
   TI
   LI
   LO
   TS
CP0042321
 Compound Info 
(S)-2-(4-(2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid
   Show/Hide
 C20H21N5O6  1
1
EC50 = 290 nM
   TI
   LI
   LO
   TS
CP0046082
 Compound Info 
(2S)-2-[(4-{2-[(6R)-2-amino-4-oxo-1H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-6-yl]ethyl}phenyl)formamido]pentanedioic acid
   Show/Hide
 C21H25N5O6  2
1
IC50 = 15.2 nM
   TI
   LI
   LO
   TS
2
IC50 = 15.78496369 nM
   TI
   LI
   LO
   TS
CP0049207
 Compound Info 
(S)-2-{4-[3-(2,4-Diamino-6-oxo-1,6-dihydro-pyrimidin-5-yl)-propylamino]-benzoylamino}-pentanedioic acid
   Show/Hide
 C19H24N6O6  1
1
IC50 = 47 nM
   TI
   LI
   LO
   TS
CP0050509
 Compound Info 
(S)-2-[4-(2,4-Diamino-5,8-dihydro-6H-pyrido[4',3':4,5]furo[2,3-d]pyrimidin-7-ylmethyl)-benzoylamino]-pentanedioic acid
   Show/Hide
 C22H24N6O6  1
1
EC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0060811
 Compound Info 
N-[(2,4-diamino-5-methylpyrido[2,3-d]pyrimidin-6-yl)methyl]-N-(3,4,5-trichlorophenyl)formamide
   Show/Hide
 C16H13Cl3N6O  1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0062042
 Compound Info 
5-(2,5-Dihydroxy-benzylamino)-2-hydroxy-N-(2-pyridin-2-yl-ethyl)-benzamide
   Show/Hide
 C21H21N3O4  1
1
GI50 = 1000 nM
   TI
   LI
   LO
   TS
CP0069893
 Compound Info 
Epivir
   Show/Hide
 C8H11N3O3S  1
1
CC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0077456
 Compound Info 
1-(beta-D-2-deoxy-erythro-pentofuranosyl)-5-fluorouracil
   Show/Hide
 C9H11FN2O5  1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0148537
 Compound Info 
2-[[4-carboxy-4-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]butyl]carbamoyl]benzoic acid
   Show/Hide
 C27H27N9O6  1
1
IC50 = 1.08 nM
   TI
   LI
   LO
   TS
CP0172998
 Compound Info 
2-R,S-[5-[(2,4-diaminopteridin-6-yl)methylamino]-2,3-dihydro-1-oxo-2(1H)-isoindolyl]glutaric acid
   Show/Hide
 C20H20N8O5  1
1
IC50 = 8.4 nM
   TI
   LI
   LO
   TS
CP0182784
 Compound Info 
2-[2-[[11-(2-aminoethylamino)-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]guanidine;hydrochloride
   Show/Hide
 C21H23ClN6O2S  1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0194921
 Compound Info 
5-(2,5-Dihydroxy-benzylamino)-2-hydroxy-N-[2-(4-methoxy-phenyl)-ethyl]-benzamide
   Show/Hide
 C23H24N2O5  1
1
GI50 = 3200 nM
   TI
   LI
   LO
   TS
CP0205751
 Compound Info 
2-[2-[[11-(3-aminopropylamino)-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]guanidine;hydrochloride
   Show/Hide
 C22H25ClN6O2S  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0214839
 Compound Info 
5-Amino-2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanoic acid
   Show/Hide
 C20H25N9O3  1
1
ED50 = 11 nM
   TI
   LI
   LO
   TS
CP0217215
 Compound Info 
2-{(S)-4-[2-(8-Amino-6-oxo-2,3,4,5,6,7-hexahydro-1H-pyrido[4,3-b]azepin-4-yl)-ethyl]-benzoylamino}-pentanedioic acid
   Show/Hide
 C23H28N4O6  1
1
IC50 = 47 nM
   TI
   LI
   LO
   TS
CP0267543
 Compound Info 
5-(2,5-Dihydroxy-benzylamino)-N-hexyl-2-hydroxy-benzamide
   Show/Hide
 C20H26N2O4  1
1
GI50 = 560 nM
   TI
   LI
   LO
   TS
CP0270683
 Compound Info 
5-(2,5-Dihydroxy-benzylamino)-2-hydroxy-N-(3-phenyl-propyl)-benzamide
   Show/Hide
 C23H24N2O4  1
1
GI50 = 2400 nM
   TI
   LI
   LO
   TS
CP0291017
 Compound Info 
2-S-[5-[2,4-diaminopteridin-6-yl)methyamino]-2,3-dihydro-1-oxo--2(1H)-isoindolyl glutaric acid
   Show/Hide
 C20H20N8O5  1
1
IC50 = 5.1 nM
   TI
   LI
   LO
   TS
CP0320349
 Compound Info 
N-benzyl-5-[(2,5-dihydroxyphenyl)methylamino]-2-hydroxybenzamide
   Show/Hide
 C21H20N2O4  1
1
GI50 = 3200 nM
   TI
   LI
   LO
   TS
CP0353114
 Compound Info 
1-[4-[[5-[6-(methylamino)pyrazin-2-yl]-2-(4-morpholin-4-ylanilino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]piperidin-1-yl]prop-2-en-1-one
   Show/Hide
 C29H33N9O3  1
1
GI50 = 127 nM
   TI
   LI
   LO
   TS
CP0358636
 Compound Info 
N-[2-(4-chlorophenyl)ethyl]-5-[(2,5-dihydroxyphenyl)methylamino]-2-hydroxybenzamide
   Show/Hide
 C22H21ClN2O4  1
1
GI50 = 1600 nM
   TI
   LI
   LO
   TS
CP0370065
 Compound Info 
5-(4-chlorophenyl)-2-(4-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
 C17H12ClN3OS  1
1
LC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0372614
 Compound Info 
5-fluoro-1-[(6S)-5-methylidene-2H-pyran-6-yl]pyrimidine-2,4-dione
   Show/Hide
 C10H9FN2O3  1
1
IC50 = 85000 nM
   TI
   LI
   LO
   TS
CP0372615
 Compound Info 
1-[(2S,4S,5R)-4,5-dihydroxy-3-methylideneoxan-2-yl]-5-fluoropyrimidine-2,4-dione
   Show/Hide
 C10H11FN2O5  1
1
IC50 = 97000 nM
   TI
   LI
   LO
   TS
CP0377885
 Compound Info 
2-amino-9-[(2R,5S)-4-fluoro-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one
   Show/Hide
 C10H10FN5O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0383276
 Compound Info 
N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine
   Show/Hide
 C16H17N3O2  1
1
GI50 = 25.3 nM
   TI
   LI
   LO
   TS
CP0387091
 Compound Info 
3-[2-[(4-aminocyclohexyl)amino]-6-[2-(morpholin-4-ylmethyl)anilino]purin-9-yl]propan-1-ol
   Show/Hide
 C25H36N8O2  1
1
GI50 > 40000 nM
   TI
   LI
   LO
   TS
CP0390610
 Compound Info 
3-[6-[4-(4-benzylpiperazin-1-yl)anilino]-2-(4-hydroxybutylamino)purin-9-yl]cyclopentan-1-ol
   Show/Hide
 C31H40N8O2  1
1
GI50 = 9085 nM
   TI
   LI
   LO
   TS
CP0410952
 Compound Info 
5-(cyclopropylsulfonylamino)-N-(3,4-difluorophenyl)-2-fluorobenzamide
   Show/Hide
 C16H13F3N2O3S  1
1
CC50 = 11800 nM
   TI
   LI
   LO
   TS
CP0421570
 Compound Info 
N-(5-methoxynaphthalen-2-yl)-N,2-dimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
   Show/Hide
 C20H21N3O  1
1
GI50 < 10 nM
   TI
   LI
   LO
   TS
CP0431938
 Compound Info 
1,5-bis[(1S)-1-(chloromethyl)-5-hydroxy-1,2-dihydrobenzo[e]indol-3-yl]pentane-1,5-dione
   Show/Hide
 C31H28Cl2N2O4  1
1
IC50 = 0.9 nM
   TI
   LI
   LO
   TS
CP0432230
 Compound Info 
N-(2,3-dihydro-1-benzofuran-5-yl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine
   Show/Hide
 C17H17N3O2  1
1
GI50 = 58.1 nM
   TI
   LI
   LO
   TS
CP0435606
 Compound Info 
CHEMBL4550659
   Show/Hide
 C33H43N9O  1
1
GI50 = 540 nM
   TI
   LI
   LO
   TS
CP0438430
 Compound Info 
2-amino-9-[(2S,5S)-4,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
   Show/Hide
 C10H11F2N5O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0445117
 Compound Info 
2-[4-[[2-[(4-aminocyclohexyl)amino]-9-cyclopentylpurin-6-yl]amino]phenyl]phenol
   Show/Hide
 C28H33N7O  1
1
GI50 = 1493 nM
   TI
   LI
   LO
   TS
CP0458046
 Compound Info 
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-[4-(2-methoxyphenyl)phenyl]purine-2,6-diamine
   Show/Hide
 C29H35N7O  1
1
GI50 = 2348 nM
   TI
   LI
   LO
   TS
CP0458049
 Compound Info 
2-N-(4-aminocyclohexyl)-6-N-[4-(5-bromopyridin-2-yl)oxyphenyl]-9-cyclopentylpurine-2,6-diamine
   Show/Hide
 C27H31BrN8O  1
1
GI50 = 6159 nM
   TI
   LI
   LO
   TS
CP0465282
 Compound Info 
4-N-(4-methoxyphenyl)-4-N-methyl-9H-pyrimido[4,5-b]indole-2,4-diamine
   Show/Hide
 C18H17N5O  1
1
GI50 = 41.1 nM
   TI
   LI
   LO
   TS
CP0468603
 Compound Info 
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-(4-pyrazol-1-ylphenyl)purine-2,6-diamine
   Show/Hide
 C25H31N9  1
1
GI50 = 933 nM
   TI
   LI
   LO
   TS
CP0468604
 Compound Info 
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[4-(1,3-thiazol-2-yloxy)phenyl]purine-2,6-diamine
   Show/Hide
 C23H28N8OS  1
1
GI50 = 8639 nM
   TI
   LI
   LO
   TS
CP0468684
 Compound Info 
5-chloro-N-[(2S)-4-methyl-1-[[(2S)-1-[[(2R)-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopentan-2-yl]-2-phenylmethoxybenzamide
   Show/Hide
 C35H42ClN3O5  1
1
GI50 = 400 nM
   TI
   LI
   LO
   TS
CP0469911
 Compound Info 
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[4-(morpholin-4-ylmethyl)phenyl]purine-2,6-diamine
   Show/Hide
 C25H36N8O  1
1
GI50 = 3035 nM
   TI
   LI
   LO
   TS
CP0470960
 Compound Info 
9-[(2S,5S)-4,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
   Show/Hide
 C10H10F2N4O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0472079
 Compound Info 
propan-2-yl (2S)-2-[[[(2R,3S,4R,5R)-4-bromo-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
   Show/Hide
 C21H26BrFN3O9P  1
1
CC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0472747
 Compound Info 
5-chloro-N-[(2S)-1-oxo-1-[[(2S)-1-oxo-3-phenylpropan-2-yl]amino]-3-phenylpropan-2-yl]-2-phenylmethoxybenzamide
   Show/Hide
 C32H29ClN2O4  1
1
GI50 = 15500 nM
   TI
   LI
   LO
   TS
CP0482235
 Compound Info 
3-[2-[(4-aminocyclohexyl)amino]-6-[4-(morpholin-4-ylmethyl)anilino]purin-9-yl]cyclopentan-1-ol
   Show/Hide
 C27H38N8O2  1
1
GI50 = 1418 nM
   TI
   LI
   LO
   TS
CP0482247
 Compound Info 
3-[2-(4-aminobutylamino)-6-[4-(morpholin-4-ylmethyl)anilino]purin-9-yl]propan-1-ol
   Show/Hide
 C23H34N8O2  1
1
GI50 = 8201 nM
   TI
   LI
   LO
   TS
CP0482748
 Compound Info 
3-[[9-cyclopentyl-6-[4-(1,3-thiazol-2-yloxy)anilino]purin-2-yl]amino]propan-1-ol
   Show/Hide
 C22H25N7O2S  1
1
GI50 = 22975 nM
   TI
   LI
   LO
   TS
CP0495582
 Compound Info 
5-chloro-N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]-2-phenylmethoxybenzamide
   Show/Hide
 C32H44ClN3O5  1
1
GI50 = 410 nM
   TI
   LI
   LO
   TS
CP0496581
 Compound Info 
(5R,6R)-1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-6-methoxy-5-methyl-1,3-diazinane-2,4-dione
   Show/Hide
 C11H16IN5O5  1
1
IC50 = 18700 nM
   TI
   LI
   LO
   TS
CP0505164
 Compound Info 
6-azido-1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-chloro-5-methyl-1,3-diazinane-2,4-dione
   Show/Hide
 C10H13ClN8O4  1
1
IC50 = 350000 nM
   TI
   LI
   LO
   TS
CP0505812
 Compound Info 
1-[(2R,5S)-4-fluoro-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione
   Show/Hide
 C10H11FN2O4  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0505871
 Compound Info 
4-amino-1-[(2S,5S)-4,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
   Show/Hide
 C9H11F2N3O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0508528
 Compound Info 
2-[2-[[4-[2-(diaminomethylideneamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-11-yl]amino]ethyl]guanidine;hydrochloride
   Show/Hide
 C22H25ClN8O2S  1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0511175
 Compound Info 
2-[2-[(11-amino-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl)amino]ethyl]guanidine;hydrochloride
   Show/Hide
 C19H18ClN5O2S  1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
CP0515183
 Compound Info 
2-[2-[[11-[2-(methylamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]guanidine;hydrochloride
   Show/Hide
 C22H25ClN6O2S  1
1
IC50 = 6000 nM
   TI
   LI
   LO
   TS
CP0519055
 Compound Info 
3-[2-[(4-aminocyclohexyl)amino]-6-[3-(morpholin-4-ylmethyl)anilino]purin-9-yl]propan-1-ol
   Show/Hide
 C25H36N8O2  1
1
GI50 > 40000 nM
   TI
   LI
   LO
   TS
CP0520025
 Compound Info 
5-chloro-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-1-[[(2S)-1-oxo-3-phenylpropan-2-yl]amino]-3-phenylpropan-2-yl]amino]pentan-2-yl]-2-phenylmethoxybenzamide
   Show/Hide
 C38H40ClN3O5  1
1
GI50 = 440 nM
   TI
   LI
   LO
   TS
CP0520028
 Compound Info 
5-chloro-N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]pentan-2-yl]amino]-1-oxopentan-2-yl]-2-phenylmethoxybenzamide
   Show/Hide
 C35H42ClN3O5  1
1
GI50 = 790 nM
   TI
   LI
   LO
   TS
CP0527496
 Compound Info 
9-[(2R,5S)-4,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
   Show/Hide
 C10H10F2N4O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0528779
 Compound Info 
(5R,6R)-1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-6-ethoxy-5-methyl-1,3-diazinane-2,4-dione
   Show/Hide
 C12H18BrN5O5  1
1
IC50 = 18500 nM
   TI
   LI
   LO
   TS
CP0529922
 Compound Info 
(5R,6R)-1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-5-methyl-6-propan-2-yloxy-1,3-diazinane-2,4-dione
   Show/Hide
 C13H20BrN5O5  1
1
IC50 > 200000 nM
   TI
   LI
   LO
   TS
CP0531516
 Compound Info 
2-amino-9-[(2R,5S)-4,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
   Show/Hide
 C10H11F2N5O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0532364
 Compound Info 
1-[(2S,5S)-4-fluoro-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione
   Show/Hide
 C10H11FN2O4  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0537559
 Compound Info 
2-[2-[[4-[2-(methylamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-11-yl]amino]ethyl]guanidine;hydrochloride
   Show/Hide
 C22H25ClN6O2S  1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0538732
 Compound Info 
5-(cyclohexylsulfonylamino)-N-(3,4-difluorophenyl)-2-fluorobenzamide
   Show/Hide
 C19H19F3N2O3S  1
1
CC50 = 74500 nM
   TI
   LI
   LO
   TS
CP0539569
 Compound Info 
4-amino-1-[(2R,5S)-4,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
   Show/Hide
 C9H11F2N3O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0541650
 Compound Info 
CHEMBL4564698
   Show/Hide
 C25H36N8O2  1
1
GI50 = 34456 nM
   TI
   LI
   LO
   TS
CP0542283
 Compound Info 
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-(4-pyrimidin-2-yloxyphenyl)purine-2,6-diamine
   Show/Hide
 C26H31N9O  1
1
GI50 = 1153 nM
   TI
   LI
   LO
   TS
CP0542452
 Compound Info 
2-[5-[[2-[(4-aminocyclohexyl)amino]-9-cyclopentylpurin-6-yl]amino]pyridin-2-yl]phenol
   Show/Hide
 C27H32N8O  1
1
GI50 = 617 nM
   TI
   LI
   LO
   TS
CP0550689
 Compound Info 
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[2-(morpholin-4-ylmethyl)phenyl]purine-2,6-diamine
   Show/Hide
 C25H36N8O  1
1
GI50 = 25661 nM
   TI
   LI
   LO
   TS
CP0550691
 Compound Info 
3-[2-(4-aminobutylamino)-6-[4-(morpholin-4-ylmethyl)anilino]purin-9-yl]cyclopentan-1-ol
   Show/Hide
 C25H36N8O2  1
1
GI50 = 5507 nM
   TI
   LI
   LO
   TS
CP0551209
 Compound Info 
4-[[9-cyclopentyl-6-[3-(morpholin-4-ylmethyl)anilino]purin-2-yl]amino]butan-1-ol
   Show/Hide
 C25H35N7O2  1
1
GI50 = 11068 nM
   TI
   LI
   LO
   TS
CP0557894
 Compound Info 
4-[[9-cyclopentyl-6-[4-(1,3-thiazol-2-yloxy)anilino]purin-2-yl]amino]butan-1-ol
   Show/Hide
 C23H27N7O2S  1
1
GI50 = 13396 nM
   TI
   LI
   LO
   TS
CP0558850
 Compound Info 
2-N-(4-aminocyclohexyl)-6-N-[4-(2-aminophenyl)phenyl]-9-cyclopentylpurine-2,6-diamine
   Show/Hide
 C28H34N8  1
1
GI50 = 677 nM
   TI
   LI
   LO
   TS
CP0560148
 Compound Info 
4-[[9-cyclopentyl-6-[4-(morpholin-4-ylmethyl)anilino]purin-2-yl]amino]butan-1-ol
   Show/Hide
 C25H35N7O2  1
1
GI50 = 3482 nM
   TI
   LI
   LO
   TS
CP0564466
 Compound Info 
5-chloro-2-hydroxy-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]benzamide
   Show/Hide
 C22H25ClN2O4  1
1
GI50 = 27700 nM
   TI
   LI
   LO
   TS
CP0570956
 Compound Info 
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[3-(morpholin-4-ylmethyl)phenyl]purine-2,6-diamine
   Show/Hide
 C25H36N8O  1
1
GI50 = 8192 nM
   TI
   LI
   LO
   TS
CP0570957
 Compound Info 
3-[2-[(4-aminocyclohexyl)amino]-6-[3-(morpholin-4-ylmethyl)anilino]purin-9-yl]cyclopentan-1-ol
   Show/Hide
 C27H38N8O2  1
1
GI50 = 1652 nM
   TI
   LI
   LO
   TS
CP0574730
 Compound Info 
4-[[6-[4-(4-benzylpiperazin-1-yl)anilino]-9-(3-hydroxypropyl)purin-2-yl]amino]butan-1-ol
   Show/Hide
 C29H38N8O2  1
1
GI50 = 27944 nM
   TI
   LI
   LO
   TS
CP0575412
 Compound Info 
3-[2-(4-aminobutylamino)-6-[4-(4-benzylpiperazin-1-yl)anilino]purin-9-yl]propan-1-ol
   Show/Hide
 C29H39N9O  1
1
GI50 = 7566 nM
   TI
   LI
   LO
   TS
CP0576088
 Compound Info 
CHEMBL4530087
   Show/Hide
 C28H34N8O  1
1
GI50 = 460 nM
   TI
   LI
   LO
   TS
CP0756592
 Compound Info 
(S)-2-{4-[2-(4-Oxo-3,4,5,6,7,8-hexahydro-pyrido[2,3-d]pyrimidin-6-yl)-ethyl]-benzoylamino}-pentanedioic acid
   Show/Hide
 C21H24N4O6  1
1
IC50 > 46679.89264 nM
   TI
   LI
   LO
   TS
CP0788593
 Compound Info 
2-[4-(2-Amino-6-methyl-4-oxo-4,4a,7,7a-tetrahydro-3H-pyrrolo[2,3-d]pyrimidin-5-ylsulfanyl)-benzoylamino]-pentanedioic acid
   Show/Hide
 C19H21N5O6S  2
1
EC50 = 450 nM
   TI
   LI
   LO
   TS
2
EC50 = 810 nM
   TI
   LI
   LO
   TS
CP0859721
 Compound Info 
1-[4-Allylamino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione
   Show/Hide
 C28H49N3O8SSi2  1
1
CC50 = 126000 nM
   TI
   LI
   LO
   TS
CP0860032
 Compound Info 
3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-8-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-3-yl]-acrylic acid methyl ester
   Show/Hide
 C28H47N3O10SSi2  1
1
CC50 = 39000 nM
   TI
   LI
   LO
   TS
CP0860730
 Compound Info 
(+)-4-Amino-1-(4-fluoro-5-hydroxymethyl-2,5-dihydro-furan-2-yl)-1H-pyrimidin-2-one
   Show/Hide
 C9H10FN3O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0863181
 Compound Info 
2-[9-(tert-Butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-4-(carbamoylmethyl-amino)-8-(3,5-dimethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-3-yl]-acetamide
   Show/Hide
 C29H51N5O10SSi2  1
1
CC50 = 3900 nM
   TI
   LI
   LO
   TS
CP0870947
 Compound Info 
1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-3-prop-1-ynyl-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione
   Show/Hide
 C28H47N3O8SSi2  1
1
CC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0874546
 Compound Info 
1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-(3-hydroxy-propenyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione
   Show/Hide
 C28H49N3O9SSi2  1
1
CC50 = 18000 nM
   TI
   LI
   LO
   TS
CP0878581
 Compound Info 
1-[9-(tert-Butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-methyl-4-methylamino-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione
   Show/Hide
 C27H49N3O8SSi2  1
1
CC50 = 234000 nM
   TI
   LI
   LO
   TS
CP0881070
 Compound Info 
1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-chloro-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione
   Show/Hide
 C24H42ClN3O8SSi2  1
1
CC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0891921
 Compound Info 
3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-8-(3,5-dimethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-3-yl]-acrylic acid methyl ester
   Show/Hide
 C29H49N3O10SSi2  1
1
CC50 = 37000 nM
   TI
   LI
   LO
   TS
CP0906523
 Compound Info 
7-Benzyl-N-(4-methoxyphenyl)-N,2,5-trimethyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride
   Show/Hide
 C23H25ClN4O  1
1
GI50 = 33.5 nM
   TI
   LI
   LO
   TS
CP0911977
 Compound Info 
N-(4-Methoxyphenyl)-N,2-dimethyl-6,7-dihydro-5H-cyclopenta-[d]pyrimidin-4-aminium Chloride
   Show/Hide
 C16H20ClN3O  1
1
GI50 < 10 nM
   TI
   LI
   LO
   TS
CP0930358
 Compound Info 
2-(3-Carbamoyl-4-(piperidin-1-yl)phenyl)-3-hydroxy-4-oxo-N-pentyl-1,4-dihydroquinoline-7-carboxamide
   Show/Hide
 C27H32N4O4  1
1
IC50 = 1730 nM
   TI
   LI
   LO
   TS
CP0944644
 Compound Info 
(-)-4-Amino-5-fluoro-1-(4-fluoro-5-hydroxymethyl-2,5-dihydro-furan-2-yl)-1H-pyrimidin-2-one
   Show/Hide
 C9H9F2N3O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0962023
 Compound Info 
5-(3-Hydroxy-4-oxo-1,4-dihydroquinolin-2-yl)-2-morpholinobenzoic Acid
   Show/Hide
 C20H18N2O5  1
1
IC50 = 49560 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2
 Cell Line Info 
Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6
 Cell Line Info 
Homo sapiens (Human) Adult acute monocytic leukemia
HL-60
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-13
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP
 Cell Line Info 
Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6
 Cell Line Info 
Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4
 Cell Line Info 
Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5
 Cell Line Info 
Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299
 Cell Line Info 
Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e
 Cell Line Info 
Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
MV4-11
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue
 Cell Line Info 
Homo sapiens (Human) Childhood acute monocytic leukemia
SEM
 Cell Line Info 
Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2
 Cell Line Info 
Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh
 Cell Line Info 
Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
Jurkat E6.1
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat
 Cell Line Info 
Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
EoL-1
 Cell Line Info 
Homo sapiens (Human) Chronic eosinophilic leukemia, not otherwise specified
CII
 Cell Line Info 
Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812
 Cell Line Info 
Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1
 Cell Line Info 
Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi
 Cell Line Info 
Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL
 Cell Line Info 
Homo sapiens (Human) Erythroleukemia
UKE-1
 Cell Line Info 
Homo sapiens (Human) Essential thrombocythemia
L-1236
 Cell Line Info 
Homo sapiens (Human) Hodgkin lymphoma
Granta-519
 Cell Line Info 
Homo sapiens (Human) Mantle cell lymphoma
JeKo-1
 Cell Line Info 
Homo sapiens (Human) Mantle cell lymphoma
Mino
 Cell Line Info 
Homo sapiens (Human) Mantle cell lymphoma
HMC-1
 Cell Line Info 
Homo sapiens (Human) Mast cell leukemia
NK-92
 Cell Line Info 
Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK
 Cell Line Info 
Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1
 Cell Line Info 
Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
RPMI-8226
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
OPM-2
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
U266B1
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
KMS-18
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
MM1.S
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
MM1.R
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
OPM-1
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40
 Cell Line Info 
Homo sapiens (Human) Plasma cell myeloma
HuT 78
 Cell Line Info 
Homo sapiens (Human) Sezary syndrome
H9
 Cell Line Info 
Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1
 Cell Line Info 
Homo sapiens (Human) Sickle cell disease
RBL-1
 Cell Line Info 
Rattus norvegicus (Rat) Rat leukemia
RBL-2H3
 Cell Line Info 
Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28
 Cell Line Info 
Homo sapiens (Human) -
JY
 Cell Line Info 
Homo sapiens (Human) -
C.M.L.
 Cell Line Info 
Homo sapiens (Human) -
BON
 Cell Line Info 
Homo sapiens (Human) -
PBMC iPSC #1
 Cell Line Info 
Homo sapiens (Human) -
LCL 721
 Cell Line Info 
Homo sapiens (Human) -